OVID icon

Ovid Therapeutics
OVID

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$3.5
129% upside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
HC Wainwright & Co
HC Wainwright & Co
Raghuram Selvaraju
50% 1-yr OVID win rate
24 Nov ‘25 9 days ago
Leerink Partners
Leerink Partners
Marc Goodman
100% 1-yr OVID win rate
17 Nov ‘25 16 days ago